Text Version
Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM
Gateway
TOXNET
Consumer
Health
Clinical Alerts
ClinicalTrials.gov
PubMed
Central
Privacy Policy
|
 |
-
Mirtazapine induces REM
sleep behavior disorder (RBD) in
parkinsonism.
Onofrj M, Luciano AL, Thomas A,
Iacono D, D'Andreamatteo G.
Department of Oncology and
Neuroscience, University G. D'Annunzio, Pescara, Italy.
onofrj@unich.it
Shortly after initiation of mirtazapine (a
noradrenergic and serotonergic antidepressant) treatment in four
patients with parkinsonism, the authors observed the appearance of REM
sleep behavior disorder (RBD). In the two patients with severe motor
symptoms, RBD was accompanied by hallucinations and confusion. These
disturbances resolved with drug discontinuation, and remained resolved
by 12- to 24-month follow-up, suggesting that RBD can be triggered by a
drug lacking anticholinergic activity.
Publication Types:
PMID: 12525729 [PubMed - indexed for
MEDLINE]
|